Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

VEGF receptor tyrosine kinase inhibitors and their use in cancer

Oct. 4, 2001

Pharmacological profile of PTK-787/ZK-222584, a new, orally active angiogenesis inhibitor

Oct. 4, 2001

Promising phase II results obtained for BBR-2778 in non-Hodgkin's lymphoma

Oct. 3, 2001

Protein kinase inhibitors reported by BASF team

Oct. 2, 2001

Naturally produced antitumor compounds identified by Aventis

Oct. 2, 2001

Orally active taxane derivatives under study at BMS

Oct. 1, 2001

Protein kinase inhibitors for cancer, cardiovascular disorders discovered at Vertex

Oct. 1, 2001

MMP inhibitor developed at Banyu induces apoptosis in human leukemia cells

Oct. 1, 2001

First NDA filing for PhotoCure in U.S.

Oct. 1, 2001

Selective cdk2 inhibitor induces apoptosis, inhibits proliferation in human tumor cells

Oct. 1, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...